Trial
NCT04071626
Evaluating Metabolic Mechanisms of Ertugliflozin in Diabetes & Heart Failure
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University Hospitals Cleveland Medical Center
Collaborators
—
Condition
Heart Failure, Diastolic
Intervention
Ertugliflozin 5 mg
Why stopped
Lack of enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-12-13